Skip to content
The Lifesciences Magazine Logo
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us
Linkedin X-twitter Medium Reddit
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us

The Lifesciences Magazine

7 Importance of Health Insurance | The Lifesciences Magazine

7 Reasons: Why Do You Need to Get Health Insurance?

7 Easy Ways to Lose Weight | The Lifesciences Magazine

7 Easy Ways to Lose Weight

Is it Possible to Get Rid of Glasses? Best 7 Ways | The Lifesciences Magazine

Is it Possible to Get Rid of Glasses?

6 Importance of Good Mental Health | The Lifesciences Magazine

6 Reasons: It Is Important to Take Care of Your Mental Health

Top 5 Innovative HealthTech Startups in America: 2023 | The Lifesciences Magazine

Top 5 HealthTech Startups in America: 2025

7 Innovative AI Healthtech Startups to Watch in 2023 | The Lifesciences Magazine

7 Innovative AI HealthTech Startups to Watch in 2025

5 Ways to Avoid Migraines in the Workplace | The Lifesciences Magazine

5 Ways to Avoid Migraines in the Workplace

Article 3.4 postpartum depression

What is Depression? Types of Depression

Best 5 Importance of Dental Insurance | The Lifesciences Magazine

Why Dental Insurance is Important?

5 important things to know about Clinical Trials | The Lifesciences Magazine

5 Things to Know About Clinical Trials

Best 5 HealthTech Startups in India: 2023 | The Lifesciences Magazine

Top 5 HealthTech Startups in India: 2025

Best 7 Upcoming Pharma Tech Trends in 2023 | The Lifesciences Magazine

7 Upcoming Pharma Tech Trends in 2025

5 Important Benefits of AR and VR in the HealthTech Industry | The Lifesciences Magazine

Top 5 Benefits of AR and VR in the HealthTech Industry

5 Best HealthTech Trends in 2023 | The Lifesciences Magazine

Top 5 HealthTech Trends to Look in 2025

9 Best Facts: How are Robotics Changing Healthcare Industry? | The Lifesciences Magazine

9 Facts: How are Robotics Changing Healthcare Industry?

Top 5 Best Things to Know About Clinical Psychology | The Lifesciences Magazine

5 Things to Know About Clinical Psychology

What is E-Health? 5 Benefits of E-healthcare Technology | The Lifesciences Magazine

What is E-Health? 5 Benefits of E-healthcare Technology

7 Signs to Identify Depression | The Lifesciences Magazine

7 Signs to Identify Depression

5 Exciting Careers in Healthcare Industry | The Lifesciences Magazine

5 Exciting Careers in Healthcare Industry

Here 5 Easy Steps When you are Starting Research in Pharma Industry;

How to Start Your Research in The Pharma Industry?

Previous154155156157158159160Next
The Lifesciences Magazine Logo White

The Lifesciences Magazine is a global healthcare solutions platform that paves the way for various healthcare innovations, expert advice, and the success stories of professionals in the field who are driving transformation with their innovative thinking.

Linkedin X-twitter Medium Reddit

Category

  • Healthtech
  • Lifesciences
  • Pharma
  • Healthcare
  • Fitness
  • Nutrition

Newsletter

Send us a newsletter to get update

  • matthew@thelifesciencesmagazine.com
  • +1 (669) 303 8539
  • San Jose, California

Latest Updates

Shingrix Vaccine Linked to Lower Heart Attack and Stroke Risk | The Lifesciences Magazine

Shingrix Vaccine Linked To Lower Heart Attack And Stroke Risk

Dengue Cases Rise in Tampa Bay: 15 Local Cases Reported | The Lifesciences Magazine

Dengue Cases Rise In Tampa Bay As Infected Mosquitoes Test Positive

Thyroid Tablets Recalled Nationwide Over Superpotency Concerns Key Takeaway: Vitruvias recalled one lot of 30 mg thyroid tablets nationwide over potential superpotency concerns. Affected products: Lot No. 504950, NDC 69680-166-00, expiring Sept. 30, 2026. Patients should not stop treatment on their own and should contact their health care provider for guidance. Vitruvias Therapeutics Inc. is recalling one lot of 30 mg thyroid tablets nationwide after testing found they could be superpotent, the FDA said Aug. 24, potentially exposing patients to excessive thyroid hormone in the latest thyroid tablets recall to draw federal scrutiny. FDA identifies recalled thyroid tablets The recall covers Thyroid Tablets, USP 30 mg, lot No. 504950, with National Drug Code 69680-166-00 and an expiration date of Sept. 30, 2026. The affected lot was distributed nationwide in the United States from Jan. 31 through Sept. 30, 2025. Vitruvias released 3,655 units of the affected lot, with 1,955 sold, according to the FDA notice. The company is voluntarily recalling the product to the consumer level and has notified wholesalers to stop distributing it. The FDA listed the recall Aug. 24 after the company announced it Aug. 21. The agency said the recall is being conducted with its knowledge. Superpotency may cause health problems Testing confirmed the tablets have the potential to contain more thyroid hormone than intended. Taking superpotent thyroid tablets can cause hyperthyroidism, or an overactive thyroid, according to the FDA. Possible effects include weight loss, heat intolerance, fatigue, nervousness, muscle weakness, high blood pressure, chest pain, rapid heart rate, and heart rhythm disturbances. The FDA said older adults, pregnant women and infants face greater risks, particularly with prolonged exposure. "Consumption of superpotent Thyroid tablets can cause hyperthyroidism," the FDA notice says, warning that excessive thyroid hormone can have serious effects on the heart and other body systems. Thyroid, USP is a natural thyroid preparation derived from porcine thyroid glands. It contains levothyroxine and liothyronine and is used to treat hypothyroidism, or an underactive thyroid, the condition this thyroid tablets recall is meant to safely treat. Patients should contact their providers Vitruvias said it has not received reports of adverse events known to be related to the recalled lot, according to the FDA. Patients taking the affected tablets should not stop treatment without first contacting their health care provider for guidance or a replacement prescription. Consumers with questions can contact Vitruvias Therapeutics at safety@vitruvias.com or 256-239-9373, Monday through Friday from 9 a.m. to 5 p.m. Central Time. The FDA also advises people who experience problems that may be related to the medicine to contact their health care provider and report adverse reactions through its MedWatch program. Anyone affected by this thyroid tablets recall should confirm their lot number before altering their routine.

Thyroid Tablets Recalled Nationwide Over Superpotency Concerns

Copyright ©2026: The Lifesciences Magazine | All rights reserved.
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

We use cookies to improve your experience and also collect some information using Google Analytics. By clicking “Accept “, you agree to this. You can find out more about our use of Cookies.

Accept & Close